文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

具核梭杆菌,一种与结直肠癌相关的口腔共生菌,通过表观遗传重编程人类结肠细胞。

, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes.

机构信息

Unité de Pathogénie Microbienne Moléculaire, INSERM U1202, Institut Pasteur, Paris, France.

Équipe universitaire EC2M3-EA7375, Université Paris- Est (UPEC), Créteil, France.

出版信息

Gut Microbes. 2023 Dec;15(2):2265138. doi: 10.1080/19490976.2023.2265138. Epub 2023 Oct 16.


DOI:10.1080/19490976.2023.2265138
PMID:37842920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10580862/
Abstract

Recently, an intestinal dysbiotic microbiota with enrichment in oral cavity bacteria has been described in colorectal cancer (CRC) patients. Here, we characterize and investigate one of these oral pathobionts, the Gram-positive anaerobic coccus . We identified two phylotypes (A and B) exhibiting different phenotypes and adhesion capabilities. We observed a strong association of phylotype A with CRC, with its higher abundance in feces and in tumoral tissue compared with the normal homologous colonic mucosa, which was associated with a distinct methylation status of patients. By developing an hypoxic co-culture system of human primary colonic cells with anaerobic bacteria, we show that phylotype A alters the DNA methylation profile promoters of key tumor-suppressor genes, oncogenes, and genes involved in epithelial-mesenchymal transition. In colonic mucosa of CRC patients carrying phylotype A, we found similar DNA methylation alterations, together with significant enrichment of differentially expressed genes in pathways involved in inflammation, cell adhesion, and regulation of actin cytoskeleton, providing evidence of possible role in the carcinogenic process.

摘要

最近,研究人员在结直肠癌(CRC)患者中描述了一种富含口腔细菌的肠道失调微生物群。在这里,我们对其中一种口腔共生菌——革兰阳性厌氧球菌进行了特征描述和研究。我们鉴定出两种具有不同表型和黏附能力的菌株(A 和 B)。我们观察到菌株 A 与 CRC 强烈相关,其在粪便和肿瘤组织中的丰度高于正常同源结肠黏膜,这与患者的特定甲基化状态有关。通过开发一种与人原代结肠细胞和厌氧菌的缺氧共培养系统,我们表明菌株 A 改变了关键肿瘤抑制基因、癌基因和参与上皮-间充质转化的基因的启动子 DNA 甲基化谱。在携带菌株 A 的 CRC 患者的结肠黏膜中,我们发现了类似的 DNA 甲基化改变,以及涉及炎症、细胞黏附和肌动蛋白细胞骨架调节的途径中差异表达基因的显著富集,为其在致癌过程中的可能作用提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/cc8b60c5ffd7/KGMI_A_2265138_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/a3900f45c5af/KGMI_A_2265138_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/d59c84778389/KGMI_A_2265138_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/fc35e860fa1c/KGMI_A_2265138_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/c9bb0d67a5df/KGMI_A_2265138_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/cc8b60c5ffd7/KGMI_A_2265138_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/a3900f45c5af/KGMI_A_2265138_UF0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/d59c84778389/KGMI_A_2265138_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/fc35e860fa1c/KGMI_A_2265138_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/c9bb0d67a5df/KGMI_A_2265138_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d2d/10580862/cc8b60c5ffd7/KGMI_A_2265138_F0004_OC.jpg

相似文献

[1]
, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes.

Gut Microbes. 2023-12

[2]
Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.

J Transl Med. 2024-10-17

[3]
Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma.

Mol Oncol. 2024-5

[4]
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.

Sci Rep. 2020-9-17

[5]
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression.

J Exp Clin Cancer Res. 2023-1-10

[6]
Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.

mBio. 2019-7-16

[7]
Who is in the driver's seat? Parvimonas micra: An understudied pathobiont at the crossroads of dysbiotic disease and cancer.

Environ Microbiol Rep. 2023-8

[8]
Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line.

Biosci Rep. 2023-6-28

[9]
Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.

Proc Natl Acad Sci U S A. 2019-11-11

[10]
Development of the First Tractable Genetic System for Parvimonas micra, a Ubiquitous Pathobiont in Human Dysbiotic Disease.

Microbiol Spectr. 2022-4-27

引用本文的文献

[1]
Contamination-controlled upper gastrointestinal microbiota profiling reveals salivary-duodenal community types linked to opportunistic pathogen carriage and inflammation.

Gut Microbes. 2025-12

[2]
Gut-derived exerts anti-cancer effects on colorectal cancer by modulating PDPN-CLEC-2 signaling pathway.

mSystems. 2025-7-22

[3]
Nanopore full length 16S rRNA gene sequencing increases species resolution in bacterial biomarker discovery.

Sci Rep. 2025-7-21

[4]
Transmission of maternal oral pathobionts to the infant gut predisposes offspring to exacerbated enteritis.

Cell Rep. 2025-7-22

[5]
DnaK of Parvimonas micra extracellular vesicles interacts with the host fibroblasts BAG3-IKK-γ axis to accelerate TNF-α secretion in oral lichen planus.

Microbiome. 2025-7-14

[6]
Exploring Antioxidant, Antimicrobial and Anti-Inflammatory Effects of and Extracts: Implications for Intestinal Dysbiosis and Colorectal Cancer Risk Associated with Oral Pathogens.

Pharmaceutics. 2025-5-25

[7]
The functional landscape of the appendix microbiome under conditions of health and disease.

Gut Pathog. 2025-6-1

[8]
The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer.

Front Oncol. 2025-4-14

[9]
Oral microbes and gastrointestinal cancers: new strategies and insights.

Clin Transl Oncol. 2025-4-5

[10]
The Oral Microbiome and Cancer.

Adv Exp Med Biol. 2025

本文引用的文献

[1]
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression.

J Exp Clin Cancer Res. 2023-1-10

[2]
Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients.

Oncogene. 2022-9

[3]
Detection of and Four Other CRC-Associated Bacteria in Patient Stools Reveals a Potential "Driver" Role for Enterotoxigenic .

Front Cell Infect Microbiol. 2022

[4]
KEGG: integrating viruses and cellular organisms.

Nucleic Acids Res. 2021-1-8

[5]
Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer.

Microbiome. 2020-7-16

[6]
Mutational signature in colorectal cancer caused by genotoxic pks E. coli.

Nature. 2020-2-27

[7]
dbEMT 2.0: An updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis.

J Genet Genomics. 2019-12-20

[8]
ShinyGO: a graphical gene-set enrichment tool for animals and plants.

Bioinformatics. 2020-4-15

[9]
Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer.

Front Pharmacol. 2019-10-31

[10]
Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.

Proc Natl Acad Sci U S A. 2019-11-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索